McMaster University
Hamilton, Ontario ON L8S 4L8
8 studies enrolling now · 69 studies all time
What they study most
ADHD, ALS, Acute Coronary Syndrome, Acute Lymphoblastic Leukemia, Adverse Reaction to Vaccine, Amyotrophic Lateral Sclerosis, Anemia of Prematurity, Anorexia Nervosa, Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Reconstruction, Aortic Stenosis, Aortic Valve Stenosis
Studies at this site
- A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A — Recruiting now
- Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection — Recruiting now
- AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis — Recruiting now
- North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) — Recruiting now
- Visible Abdominal Distension — Recruiting now
- Abatacept in Immune Checkpoint Inhibitor Myocarditis — Recruiting now
- Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa — Recruiting now
- COVID-19 Vaccines Safety Tracking (CoVaST) — Recruiting now
- SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma — Running, not enrolling
- STABILITY 2: Anterior Cruciate Ligament Reconstruction +/- Lateral Tenodesis With Patellar vs Quad Tendon — Running, not enrolling
- Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough — Running, not enrolling
- Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks — Completed
- A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
- Reference Values for Videofluoroscopic Measures of Swallowing — Enrolling by invitation
- Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B — Running, not enrolling
- Study to Assess the Safety, Tolerability, PK and PD of ABX1100 — Completed
- Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet — Completed
- A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease — Completed
- A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes — Completed
- A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) — Completed
- A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors — Completed
- Extension Study of AG-348 in Adult Participants With Pyruvate Kinase Deficiency Previously Enrolled in AG-348-006 or AG348-C-007 — Completed
- Standardized Invasive Hemodynamics for Elevated Gradients Post TAVR (DISCORDANCE TAVR) — Completed
- Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B — Completed
- REGENETEN™ Bioinductive Implant System in Full-thickness Tears — Stopped early
- A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
- Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
- Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) — Stopped early
- A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) — Stopped early
- Swallowing Impairment After COVID-19 Infection — Completed
- IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF) — Completed
- Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM) — Stopped early
- A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B — Completed
- Feasibility Study Comparing Standard FBT and Guided Self-Help FBT for Adolescent Anorexia Nervosa — Completed
- MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma — Completed
- A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema — Completed
- Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A — Completed
- Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease — Completed
- Comparing Total Hip Arthroplasty and Hemi-Arthroplasty on Secondary Procedures and Quality of Life in Adults With Displaced Hip Fractures — Completed
- Pyruvate Kinase Deficiency Natural History Study — Completed
- Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus — Completed
- Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III — Completed
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM) — Completed
- Syncope: Pacing or Recording in the Later Years — Completed
- A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment — Stopped early
- Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) — Completed
- GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM) — Completed
- Caffeine for Apnea of Prematurity (CAP) — Completed
- Inhaled Nitric Oxide Study for Respiratory Failure in Newborns — Stopped early
- Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial — Completed